Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Advantage Silver Dental Arrest, LLC
With
University of Washington
The FDA requested additional data to evaluate the pharmacokinetics of silver diamine fluoride (SDF, Advantage Arrest) in children 13 months to 13 years old. The first request is for children under 36 months of age to be included in a study. The second request is for serum silver concentration be evaluated for a longer duration post-application to better estimate the half-life of silver and return of serum silver to baseline levels in children.
Age
1–13
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
At least one untreated caries lesion into the dentin
Live within 10 miles of study site
You may not be if
oral mucositis
ulcerative oral lesions
hypersensitivity to silver or fluoride
history of treatment with silver diamine fluoride within 3 months
